Late Preterm Births Present Serious Risks to Newborns
New study published in The Journal of Pediatrics
Cincinnati, OH, December 11, 2008 -- More than half a million babies are born preterm in the United States each year, and preterm births are on the rise. Late preterm births, or births that occur between 34 and 36 weeks (approximately 4 to 6 weeks before the mother’s due date), account for more than 70% of preterm births. Despite the large number of affected babies, many people are unaware of the serious health problems related to late preterm births. A new study and an accompanying editorial soon to be published in The Journal of Pediatrics investigate the serious neurological problems associated with late preterm births.
Dr. Joann Petrini of the March of Dimes and colleagues from institutions throughout the United States studied more than 140,000 babies born between 2000 and 2004, ranging from preterm (30-37 weeks) to full term (37-41 weeks). The researchers evaluated the babies’ neurological development and found that late preterm babies were more than three times as likely to be diagnosed with cerebral palsy as full term babies. They also found that late preterm babies were at an increased risk for developmental delay or mental retardation.
Editorialist Dr. Michael Kramer of McGill University points out that the “rates of preterm births are increasing, especially in the United States, and the associated risks are a serious public health concern.” He sees the increasing number of twins and induced labors as contributing factors in the rise of preterm births. “The rise in twins may be due to the use of fertility treatments like hormones and in-vitro fertilization,” Dr. Kramer explains. However, he notes that the increased risks may not always come from early delivery itself, but from other underlying problems, such as gestational diabetes, that may lead to early delivery.
According to Dr. Petrini, “The negative outcomes of many babies born late preterm can no longer be described as temporary or benign.” She suggests that late preterm babies may benefit from neuron-developmental assessments and stresses that elective delivery through cesarean section or induction should not be performed before 39 weeks unless medically necessary. Additionally, Dr. Kramer urges mothers and families to be aware of the risks when considering infertility treatments and induction of labor.
The study is reported in “Increased Risk of Adverse Neurological Development for Late Preterm Infants” by Joann Petrini, PhD, MPH, Todd Dias, MS, Marie C. McCormick, MD, ScD, Maria L. Massolo, PhD, Nancy S. Green, MD, and Gabriel J. Escobar, MD. The editorial is: “Late Preterm Birth: Appreciable Risks, Rising Incidence” by Michael S. Kramer, MD. The articles appear in The Journal of Pediatrics, published by Elsevier.
About The Journal of Pediatrics
The Journal of Pediatrics is a primary reference for the science and practice of pediatrics and its subspecialties. This authoritative resource of original, peer-reviewed articles oriented toward clinical practice helps physicians stay abreast of the latest and ever-changing developments in pediatric medicine. The Journal of Pediatrics is ranked 3rd out of 78 pediatric medical journals (2007 Journal Citation Reports, published by Thomson Reuters).
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 513 636 7140